Bessemer Group’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-3,156
| Closed | -$580K | – | 1790 |
|
|
2021
Q2 | $580K | Buy |
3,156
+124
| +4% | +$21.3K | ﹤0.01% | 529 |
|
|
2021
Q1 | $464K | Sell |
3,032
-24
| -0.8% | -$3.71K | ﹤0.01% | 555 |
|
|
2020
Q4 | $478K | Buy |
3,056
+313
| +11% | +$40.2K | ﹤0.01% | 541 |
|
|
2020
Q3 | $313K | Sell |
2,743
-6,663
| -71% | -$719K | ﹤0.01% | 620 |
|
|
2020
Q2 | $1.06M | Buy |
9,406
+9,187
| +4,195% | +$975K | ﹤0.01% | 758 |
|
|
2020
Q1 | $20K | Buy |
219
+205
| +1,464% | +$20.1K | ﹤0.01% | 1365 |
|
|
2019
Q4 | $2K | Sell |
14
-415
| -97% | -$44.4K | ﹤0.01% | 1573 |
|
|
2019
Q3 | $42K | Buy |
429
+329
| +329% | +$37.1K | ﹤0.01% | 1302 |
|
|
2019
Q2 | $13K | Sell |
100
-776
| -89% | -$100K | ﹤0.01% | 1465 |
|
|
2019
Q1 | $118K | Sell |
876
-1,220
| -58% | -$152K | ﹤0.01% | 1106 |
|
|
2018
Q4 | $203K | Sell |
2,096
-1,108,319
| -100% | -$131M | ﹤0.01% | 976 |
|
|
2018
Q3 | $154M | Buy |
1,110,415
+20,723
| +2% | +$2.6M | 0.57% | 63 |
|
|
2018
Q2 | $135M | Buy |
1,089,692
+351,907
| +48% | +$41.1M | 0.52% | 70 |
|
|
2018
Q1 | $82.2M | Buy |
737,785
+12,289
| +2% | +$1.47M | 0.32% | 106 |
|
|
2017
Q4 | $86.8M | Sell |
725,496
-7,076
| -1% | -$862K | 0.34% | 100 |
|
|
2017
Q3 | $103M | Buy |
732,572
+11,168
| +2% | +$1.52M | 0.41% | 94 |
|
|
2017
Q2 | $87.8M | Buy |
721,404
+721,367
| +1,949,641% | +$84M | 0.35% | 96 |
|
|
2017
Q1 | $4K | Sell |
37
-25
| -40% | -$3.22K | ﹤0.01% | 1645 |
|
|
2016
Q4 | $7K | Sell |
62
-255
| -80% | -$31.2K | ﹤0.01% | 1697 |
|
|
2016
Q3 | $39K | Sell |
317
-417
| -57% | -$53.7K | ﹤0.01% | 1241 |
|
|
2016
Q2 | $86K | Buy |
734
+83
| +13% | +$11.8K | ﹤0.01% | 790 |
|
|
2016
Q1 | $91K | Sell |
651
-1,307
| -67% | -$192K | ﹤0.01% | 801 |
|
|
2015
Q4 | $374K | Buy |
1,958
+475
| +32% | +$83K | ﹤0.01% | 662 |
|
|
2015
Q3 | $232K | Buy |
1,483
+1,288
| +661% | +$235K | ﹤0.01% | 745 |
|
|
2015
Q2 | $35K | Buy |
195
+22
| +13% | +$3.8K | ﹤0.01% | 1041 |
|
|
2015
Q1 | $30K | Sell |
173
-280
| -62% | -$50.7K | ﹤0.01% | 1070 |
|
|
2014
Q4 | $84K | Buy |
453
+78
| +21% | +$14.5K | ﹤0.01% | 836 |
|
|
2014
Q3 | $62K | Buy |
375
+148
| +65% | +$24.3K | ﹤0.01% | 839 |
|
|
2014
Q2 | $35K | Buy |
+227
| New | +$35.8K | ﹤0.01% | 929 |
|
|
2013
Q3 | – | Sell |
-500
| Closed | -$46K | – | 1408 |
|
|
2013
Q2 | $46K | Buy |
+500
| New | +$48.2K | ﹤0.01% | 786 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM